Pain Management for Osteoarthritis: Guideline Toplines
Get a topline review of OA pain management recommendations from the Osteoarthritis Research Society International and the American College of Rheumatology/Arthritis Foundation.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of February 10, 2021
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
Seen in the ED: Progressive Isolated Finger Pain
A man in his fifties presents with pain in a fingertip that has been getting increasingly worse. Notable on exam are a small scab on that finger and nail-bitten fingernails. Your Dx?
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of February 9, 2021
Stress Management 2021: The Case for Self-Care in the COVID-19 Era
Obesity Medicine Association President Craig Primack, MD, reminds PCPs that stress management is a key to good self care for everyone and offers tips to share with patients.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of February 8, 2021
Global confirmed cases of COVID-19 have surpassed 106 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
A1c Variability Predicts CVD in Type 2 Diabetes, Hypoglycemia May Mediate Impact
Variability in A1c during the first 2 years after T2D diagnosis is a strong predictor of CV disease; study authors note the risk may be mediated by severe hypoglycemic episodes.
AHA 2021 Statistical Update: Pandemic Impact on CVD Will Be "Exponential"
Heart disease, again the leading cause of death worldwide, may remain so for many years as a result of COVID-19 pandemic conditions, says AHA Update Writing Committee Chair.
Racial Disparities in COVID-19 Vaccination: Data from 23 States
Kaiser Family Foundation: New data from 23 states show consistently smaller shares of vaccination among Blacks vs Whites based on share of cases and deaths and of total population.
Johnson & Johnson Submits EUA for its Single-Dose COVID-19 Vaccine Candidate
The submission is based on data from the phase 3 ENSEMBLE clinical trial that showed the investigational single-dose vaccine met all primary and key secondary endpoints.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of February 5, 2021
Global confirmed cases of COVID-19 have surpassed 105 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Antidepressants for Back Pain and OA Pain: Study Finds Room for Re-evaluation
Antidepressants, although guideline-recommended and widely prescribed for common pain conditions, may not be as effective as perceived. Author of a new meta-analysis explains.
Pfizer, Oxford-AstraZeneca Vaccines to be Studied in Alternating Doses
Oxford researchers will evaluate the interchangeability of the vaccines, the impact of different dosing intervals, and the potential for enhanced immune response.
Alternative Therapies for Pain: What’s the Latest Evidence?
Acupuncture, massage, meditation—what does the latest research say about these and other popular alternative therapies for pain management?
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of February 4, 2021
George Bakris, MD: Heart Failure, Renal Disease, CV Risk Research is on Fire
Video: George Bakris, MD says over the next 3 years there is going to be an "explosion" in the number of studies we see in heart failure, diabetic kidney disease, and CV risk in general.
AstraZeneca, University of Oxford COVID-19 Vaccine Effective for Disease Prevention, Reducing Spread
A new primary analysis found that the AstraZeneca and University of Oxford COVID-19 vaccine is safe and effective at preventing infection and reducing transmission.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of February 3, 2021
Treating Episodic Migraine Headaches: Evidence for Drug and Nondrug Therapies
Migraine headaches are a condition commonly seen in primary care. Here is a top-line look at the evidence for efficacy of the wide range of treatments available.
Hyaluronan Improves Respiratory Failure in Acute Exacerbation of COPD
Hyaluronan represents a new class of biologic that significantly improves lung health in patients with severe COPD.